CDMO– tag –
-
Continuous Upstream Bioprocessing Gains Traction, WuXi Biologics Pioneers Fully Automated Perfusion Platform for Enhanced Productivity
Pharma Manufacturing USA Overview Continuous upstream bioprocessing, especially perfusion culture, is significantly enhancing productivity and consistency in biomanufacturing. CDMOs are increasing investments in continuous bioprocessing ... -
Northway Biotech Opens €61M Cell Therapy and Personalized Medicine CDMO in Vilnius, Marking Baltic Region’s First
PR Newswire Lithuania Overview Northway Biotech has launched a pioneering €61 million ($65M USD) cell therapy and personalized medicine CDMO facility in Vilnius, Lithuania, establishing the first such hub in the Baltics. This 3,500-squar... -
The Multispecific Antibody Revolution: Reshaping CDMOs for Next-Gen Biologics
BioSpace USA Overview The rapid advancement of multispecific antibody therapeutics is fundamentally transforming the service delivery models and development architectures of Contract Development and Manufacturing Organizations (CDMOs). T... -
Samsung Biologics to Acquire PolyPeptide Group for $1.8B, Expanding CDMO Capabilities into Peptide Therapeutics with $2.2B Capital Raise
Endpoints News South Korea Overview Samsung Biologics announced a capital raise of nearly $2.2 billion to fund its long-term growth strategy, including the acquisition of PolyPeptide Group for $1.8 billion. This acquisition will signific... -
CDMO Curia Massively Expands Sterile Fill-Finish Capacity in UK, US for Biologics and ADCs
Packaging Digest UK, USA Overview CDMO Curia has significantly expanded its sterile fill-finish manufacturing facilities in Glasgow, UK, and Albuquerque, US, to meet surging demand for biologics and highly potent antibody-drug conjugates... -
Genprex Taps Andelyn Biosciences to Accelerate Manufacturing Scale-Up for Diabetes Gene Therapy Program
Contract Pharma USA Overview Clinical-stage company Genprex has selected Andelyn Biosciences as its CDMO to scale up manufacturing for its diabetes gene therapy program. Leveraging its proprietary Curator Cell and Gene Therapy Platform, ... -
Cellipont Bioservices’ Texas Facility Propels Six Client Cell Therapy Programs to Expected 2026 IND Submissions
PR Newswire (Cellipont Bioservices) USA Overview Cellipont Bioservices, a cell therapy CDMO, announced that its Texas facility has supported six client projects anticipated to reach Investigational New Drug (IND) submission in 2026. This... -
Northway Biotech Launches €61M Cell Therapy CDMO in Lithuania, Scaling Advanced Biologics for Global Demand
PR Newswire (Northway Biotech) Lithuania Overview Northway Biotech has inaugurated a state-of-the-art €61 million cell therapy and personalized medicine CDMO facility in Vilnius, Lithuania. This 3,500-square-meter site boasts up to 20 in... -
Northway Biotech Inaugurates €61 Million Cell Therapy CDMO Facility in Vilnius, First in the Baltics
PR Newswire Lithuania Overview Northway Biotech has invested €61 million to establish the Baltic states' first large-scale Contract Development and Manufacturing Organization (CDMO) facility for cell therapy and personalized medicine in ... -
4basebio and Genezen Partner to Revolutionize Viral Vector Manufacturing: hpDNA Boosts AAV Titers by up to 33-fold
AllSci Overview 4basebio and Genezen have announced a strategic collaboration to integrate 4basebio's hpDNA platform into viral vector manufacturing workflows, aiming to significantly enhance efficiency. This innovative cell-free synthet...
